Tirzepatide, a novel medication, is creating considerable interest within the healthcare community. It functions differently from traditional diabetes therapies , targeting two receptors involved in glucose regulation and hunger . Initial trials have demonstrated remarkable efficacy in reducing blood glucose in individuals with adult-onset diabetes